Plasma Beta-Glucuronidase Levels in Breast Cancer
Author Information
Author(s): B. L. Whitaker
Primary Institution: Royal Free Hospital
Hypothesis
The study investigates the plasma levels of beta-glucuronidase in patients with breast cancer compared to normal controls.
Conclusion
The study found that plasma beta-glucuronidase levels are significantly higher in breast cancer patients compared to normal women.
Supporting Evidence
- The mean beta-glucuronidase level for breast cancer patients was 6.90 units, significantly higher than the control group's mean of 3.58 units.
- 51% of breast cancer cases had enzyme levels within the normal range, while 49% had elevated levels.
- Stage I and II breast cancer cases had significantly raised enzyme levels compared to controls.
Takeaway
This study looked at a special enzyme in the blood of women with breast cancer and found that they had more of it than women without cancer.
Methodology
Blood samples were taken, plasma was separated and stored, and enzyme levels were measured using a modified method of estimation.
Limitations
The study does not provide data on the effects of treatment on enzyme levels, which will be reported later.
Participant Demographics
The study included 50 normal women aged 18 to 70 and 47 patients with breast carcinoma.
Statistical Information
P-Value
<0.0000001
Statistical Significance
p<0.0000001
Want to read the original?
Access the complete publication on the publisher's website